FDA Inspection 930547 — Grifols Biomat
The FDA completed an inspection of Grifols Biomat on June 11, 2015 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Reading, PA (United States)